DCX and Alzheimer disease: An increase of BrdU+ and DCX+ cells in the SGZ was noted after oral treatment with the non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen and naproxen, for nine weeks, beginning at three weeks of age, thus, indicating the association between reducing neuroinflammation and enhancing neurogenesis in AD transgenic mice.